As of 2024-12-14, the EV/EBITDA ratio of Cardlytics Inc (CDLX) is -6.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Cardlytics's latest enterprise value is 335.81 mil USD. Cardlytics's TTM EBITDA according to its financial statements is -55.01 mil USD. Dividing these 2 quantities gives us the above Cardlytics EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.9x - 6.2x | 4.5x |
| Forward P/E multiples | 2.8x - 6.1x | 4.2x |
| Fair Price | (7.12) - (9.44) | (7.61) |
| Upside | -290.9% - -353.0% | -304.1% |
| Date | EV/EBITDA |
| 2024-12-13 | -6.10 |
| 2024-12-12 | -5.97 |
| 2024-12-11 | -6.29 |
| 2024-12-10 | -6.40 |
| 2024-12-09 | -6.22 |
| 2024-12-06 | -6.31 |
| 2024-12-05 | -6.20 |
| 2024-12-04 | -6.19 |
| 2024-12-03 | -6.28 |
| 2024-12-02 | -6.44 |
| 2024-11-29 | -6.42 |
| 2024-11-27 | -6.33 |
| 2024-11-26 | -6.30 |
| 2024-11-25 | -6.37 |
| 2024-11-22 | -6.29 |
| 2024-11-21 | -6.17 |
| 2024-11-20 | -6.05 |
| 2024-11-19 | -5.90 |
| 2024-11-18 | -5.84 |
| 2024-11-15 | -5.78 |
| 2024-11-14 | -5.98 |
| 2024-11-13 | -6.22 |
| 2024-11-12 | -6.57 |
| 2024-11-11 | -6.86 |
| 2024-11-08 | -6.70 |
| 2024-11-07 | -6.42 |
| 2024-11-06 | -7.47 |
| 2024-11-05 | -6.99 |
| 2024-11-04 | -6.53 |
| 2024-11-01 | -6.52 |
| 2024-10-31 | -6.64 |
| 2024-10-30 | -6.48 |
| 2024-10-29 | -6.34 |
| 2024-10-28 | -6.39 |
| 2024-10-25 | -6.24 |
| 2024-10-24 | -6.15 |
| 2024-10-23 | -6.20 |
| 2024-10-22 | -6.28 |
| 2024-10-21 | -6.43 |
| 2024-10-18 | -6.33 |
| 2024-10-17 | -6.31 |
| 2024-10-16 | -6.21 |
| 2024-10-15 | -6.15 |
| 2024-10-14 | -6.14 |
| 2024-10-11 | -5.98 |
| 2024-10-10 | -5.63 |
| 2024-10-09 | -5.67 |
| 2024-10-08 | -5.58 |
| 2024-10-07 | -5.57 |
| 2024-10-04 | -5.70 |